These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 9723944)

  • 41. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
    Watts SW; Thompson JM
    J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Failure to detect in vivo inverse agonism of the 5-HT(1B) receptor antagonist SB-224289 in 5-HT-depleted guinea-pigs.
    Stenfors C; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):462-7. PubMed ID: 12070760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HT-mediated human cavernosal contraction.
    Lau DH; Thompson CS; Bellringer JF; Thomas PJ; Mumtaz FH; Morgan RJ; Mikhailidis DP
    J Androl; 2006; 27(5):679-85. PubMed ID: 16728720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertensive rats.
    Watts SW; Baez M; Webb RC
    J Pharmacol Exp Ther; 1996 May; 277(2):1103-13. PubMed ID: 8627522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.
    Jähnichen S; Radtke OA; Pertz HH
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):54-63. PubMed ID: 15185063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization.
    Cohen Z; Bouchelet I; Olivier A; Villemure JG; Ball R; Stanimirovic DB; Hamel E
    J Cereb Blood Flow Metab; 1999 Aug; 19(8):908-17. PubMed ID: 10458598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.
    van den Broek RW; Bhalla P; VanDenBrink AM; de Vries R; Sharma HS; Saxena PR
    Cephalalgia; 2002 Mar; 22(2):83-93. PubMed ID: 11972574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Promotion of cell growth by stimulation of cloned human 5-HT1D receptor sites in transfected C6-glial cells is highly sensitive to intrinsic activity at 5-HT1D receptors.
    Pauwels PJ; Wurch T; Palmier C; Colpaert FC
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):136-44. PubMed ID: 8857590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.
    Kaumann AJ; Frenken M; Posival H; Brown AM
    Circulation; 1994 Sep; 90(3):1141-53. PubMed ID: 8087924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats.
    Jeong CY; Choi JI; Yoon MH
    Eur J Pharmacol; 2004 Oct; 502(3):205-11. PubMed ID: 15476746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GR127935 is a potent antagonist of the 5-HT1-like receptor mediating contraction in the canine coronary artery.
    Terrón JA
    Eur J Pharmacol; 1996 Apr; 300(1-2):109-12. PubMed ID: 8741174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of putative 5-HT7 receptors mediating tachycardia in the cat.
    Villalón CM; Heiligers JP; Centurión D; De Vries P; Saxena PR
    Br J Pharmacol; 1997 Jul; 121(6):1187-95. PubMed ID: 9249256
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of 5-hydroxytryptamine receptors in rabbit isolated iliac artery.
    Yildiz O; Tuncer M
    Arch Int Pharmacodyn Ther; 1993; 326():72-83. PubMed ID: 8185415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels.
    Bouchelet I; Cohen Z; Case B; Séguéla P; Hamel E
    Mol Pharmacol; 1996 Aug; 50(2):219-23. PubMed ID: 8700126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
    Pullar IA; Boot JR; Broadmore RJ; Eyre TA; Cooper J; Sanger GJ; Wedley S; Mitchell SN
    Eur J Pharmacol; 2004 Jun; 493(1-3):85-93. PubMed ID: 15189767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 2. Evidence of involvement of 5-HT1B receptors using functional studies.
    Rogines-Velo MP; Pelorosso FG; Zold CL; Brodsky PT; Rothlin RP
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):596-604. PubMed ID: 12444502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonist.
    Scott C; Langmead CJ; Clarke KL; Wyman P; Smith PW; Starr KR; Dawson LA; Price GW; Hagan JJ; Watson J
    Neuropharmacology; 2006 Jun; 50(8):984-90. PubMed ID: 16546225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors.
    Price GW; Burton MJ; Collin LJ; Duckworth M; Gaster L; Göthert M; Jones BJ; Roberts C; Watson JM; Middlemiss DN
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):312-20. PubMed ID: 9303567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.
    Edvinsson L; Uddman E; Wackenfors A; Davenport A; Longmore J; Malmsjö M
    Clin Sci (Lond); 2005 Sep; 109(3):335-42. PubMed ID: 15853772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.